Table 1.

MINT Eligibility Criteria

Inclusion Criteria:
1)	18 years of age or older;
2)	with either ST-segment elevation myocardial infarction or non-ST-segment elevation myocardial infarction consistent with the Third Universal Definition of Myocardial Infarction and Type 1 (spontaneous), Type 2 (oxygen supply/demand mismatch), Type 4b (stent thrombosis at angiography), or Type 4c (in-stent restenosis)13 that occurs on admission or during the index hospitalization,
3)	with a hemoglobin concentration less than 10 g/dL at the time of random allocation, and
4)	4) the patient’s attending physician, with expertise in cardiovascular care, believes that both of the transfusion strategies are consistent with good medical care for the patient as determined by his/her clinical judgement.
Exclusion Criteria:
1)	uncontrolled acute bleeding at the time of randomization defined as the need for uncrossed or non-type specific blood;
2)	decline blood transfusion;
3)	scheduled for cardiac surgery during the current admission;
4)	are receiving only palliative treatment;
5)	if known that follow-up will not be possible at 30 days;
6)	if previously participated in MINT
7)	if currently enrolled in a competing study that interferes with the intervention or follow-up of MINT or enrolled in a competing study that has not been approved by the local IRB; or
8)	if the attending physician does not believe the patient is an appropriate candidate for the trial for any reason.